Rosenberger announces expansion project at Alkermes in Clinton County
Lead Summary
By
Press Release-
Speaker of the Ohio House Clifford A. Rosenberger (R-Clarksville) announced Wednesday that Alkermes, a global biopharmaceutical company with a facility in Clinton County, has been recently approved for a new project through the Ohio Tax Credit Authority.
The expansion project would work to retain more than 400-plus jobs, create more than 90 new jobs and add $5.3 million to the payroll.
[[In-content Ad]]
“It is tremendous news to hear about this new expansion project at Alkermes in Wilmington,” Speaker Rosenberger said. “For the Clinton County community, it is another step we can take in improving our economic landscape and enhancing our workforce development.
“I applaud JobsOhio and the Dayton Development Coalition for their work on this, and I look forward to seeing the impact this project will have on families in the area. The economic team in Clinton County also deserves special recognition for showing Ohio and the nation just how much Wilmington has to offer.”
Alkermes develops and manufactures pharmaceuticals for major clinical conditions such as schizophrenia, addiction and depression. They also develop Vivitrol, a medication for the treatment of alcohol and opioid dependence. As a leader in biopharmaceuticals, they have facilities in Ireland, Massachusetts and Ohio.
The expansion project would work to retain more than 400-plus jobs, create more than 90 new jobs and add $5.3 million to the payroll.
[[In-content Ad]]
“It is tremendous news to hear about this new expansion project at Alkermes in Wilmington,” Speaker Rosenberger said. “For the Clinton County community, it is another step we can take in improving our economic landscape and enhancing our workforce development.
“I applaud JobsOhio and the Dayton Development Coalition for their work on this, and I look forward to seeing the impact this project will have on families in the area. The economic team in Clinton County also deserves special recognition for showing Ohio and the nation just how much Wilmington has to offer.”
Alkermes develops and manufactures pharmaceuticals for major clinical conditions such as schizophrenia, addiction and depression. They also develop Vivitrol, a medication for the treatment of alcohol and opioid dependence. As a leader in biopharmaceuticals, they have facilities in Ireland, Massachusetts and Ohio.